太陽娛樂集團(08082.HK)配發3300萬股
格隆匯11月19日丨太陽娛樂集團(08082.HK)公佈,於11月19日,公司及光尚文化與顧問Tse Kar Ho Simon訂立戰略合作協議。
根據戰略合作協議,公司於合作期內每三個月向顧問支付6萬港元作為其顧問費。根據戰略合作協議,公司亦向顧問配發及發行3300萬股股份。
公告顯示,新股份相當於公司於公佈日期現有已發行股份約2.71%;及(ii)經擴大股份約2.64%。
根據於戰略合作協議日期股份收市價0.67港元計算,發行3300萬股新股份貨幣價值約為2210萬港元,連同合作期內將支付總顧問費72萬港元,而相較保證溢利3000萬港元,應付顧問款項總額較保證溢利折讓約23.9%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.